Anwaar Saeed, Jun Zhang, Babar Bashir, Alexander Philipovskiy, Robert William Lentz, Shira Amsili, Rinat Tabakman, Maria Marinova, Yaffa Shwartz, Adam Foley-Comer, Antonio Jimeno. "Phase 2 dose expansion study of DSP107, a first-in-class bi-specific 4-1BB T-cell engager, with and without atezolizumab in metastatic MSS colorectal cancer patients.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.3517